LONDON BROKER RATINGS: Experian on JPMorgan focus list at 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations on Thursday morning and on Wednesday: Read More
| Price | 351.20p on 13-02-2026 at 19:40:05 |
|---|---|
| Change | -7.40p -2.06% |
| Buy | 351.60p |
| Sell | 351.00p |
| Last Trade: | Sell 314,725.00 at 351.20p |
| Day's Volume: | 1,075,050 |
| Last Close: | 351.20p |
| Open: | 358.40p |
| ISIN: | GB00BM8NFJ84 |
| Day's Range | 348.40p - 358.40p |
| 52wk Range: | 300.00p - 501.00p |
| Market Capitalisation: | £1.22b |
| VWAP: | 351.41763p |
| Shares in Issue: | 346.68m |
Breedon (BREE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 314,725 | 351.20p | Uncrossing Trade |
16:35:23 - 13-Feb-26 |
| Buy* | 15 | 351.40p | Automatic Execution |
16:29:55 - 13-Feb-26 |
| Buy* | 34 | 351.40p | Automatic Execution |
16:29:55 - 13-Feb-26 |
| Buy* | 33 | 351.40p | Automatic Execution |
16:29:36 - 13-Feb-26 |
| Buy* | 33 | 351.40p | Automatic Execution |
16:29:36 - 13-Feb-26 |
| Buy* | 17 | 351.20p | Automatic Execution |
16:29:34 - 13-Feb-26 |
| Buy* | 778 | 351.20p | Automatic Execution |
16:29:34 - 13-Feb-26 |
| Sell* | 56 | 351.20p | Automatic Execution |
16:29:34 - 13-Feb-26 |
| Sell* | 6 | 351.20p | Automatic Execution |
16:29:34 - 13-Feb-26 |
| Sell* | 76 | 351.40p | Automatic Execution |
16:28:55 - 13-Feb-26 |
Breedon (BREE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Feb 2026 4:01 pm | RNS | Issue of Shares |
| 30th Jan 2026 12:44 pm | RNS | Block Listing Update |
| 30th Jan 2026 7:00 am | RNS | Notice of Annual Results 2025 |
| 31st Dec 2025 7:00 am | RNS | BLOCK LISTING SIX MONTHLY RETURN |
| 31st Dec 2025 7:00 am | RNS | Total Voting Rights |
| 2nd Dec 2025 3:49 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2025 3:29 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2025 8:55 am | RNS | Total Voting Rights |
| 26th Nov 2025 5:20 pm | RNS | Director/PDMR Shareholding |
| 21st Nov 2025 7:00 am | RNS | Director/PDMR Shareholding |